95-1466. Findings of Scientific Misconduct
[Federal Register Volume 60, Number 13 (Friday, January 20, 1995)]
[Notices]
[Page 4169]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-1466]
[[Page 4169]]
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Findings of Scientific Misconduct
AGENCY: Office of the Secretary, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: Notice is hereby given that the Office of Research Integrity
(ORI) has made final findings of scientific misconduct in the following
case:
David F. Eierman, Ph.D., University of North Carolina at Chapel
Hill: The Division of Research Investigations (DRI) of the Office of
Research Integrity (ORI) reviewed an investigation conducted by the
University of North Carolina at Chapel Hill into possible scientific
misconduct on the part of Dr. Eierman while a research assistant at the
University of North Carolina. Based in part on Dr. Eierman's admission,
the University concluded that he committed scientific misconduct by
falsifying or fabricating data in biomedical research supported by two
Public Health Service grants. The ORI accepted the University's
conclusions and found that Dr. Eierman engaged in scientific
misconduct.
Dr. Eierman has fully cooperated with the University of North
Carolina and ORI in this matter and has signed a Voluntary Exclusion
Agreement under which he has agreed to be excluded from support under
Federal grants, contracts, and cooperative agreements for a three-year
period beginning December 12, 1994, and ending December 11, 1997, and
from service on PHS advisory committees, boards, or peer review groups
for the same period. ORI notes that Dr. Eierman's cooperation in
resolving this matter indicates that he has accepted responsibility for
his actions, and this is regarded as a positive factor that was taken
into consideration in negotiating the Voluntary Exclusion Agreement.
The fabricated and falsified data were reported in two manuscripts that
were never published and in Figure 3 of ``1 and
2 Integrin Subunit Regulation of the Monocyte
Inflammatory Response,'' Cellular and Cytokine Networks in Tissue
Immunity (M. Meltzer, and A. Mantovani, Eds.). (1991). New York: Wiley-
Liss.
FOR FURTHER INFORMATION CONTACT: Director. Division of Research
Investigations, Office of Research Integrity, 301-443-5330.
Lyle W. Bivens, Ph.D.
Director, Office of Research Integrity.
[FR Doc. 95-1466 Filed 1-19-95; 8:45 am]
BILLING CODE 4160-17-P-M
Document Information
- Published:
- 01/20/1995
- Department:
- Health and Human Services Department
- Entry Type:
- Notice
- Action:
- Notice.
- Document Number:
- 95-1466
- Pages:
- 4169-4169 (1 pages)
- PDF File:
-
95-1466.pdf